𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II study of LU 103793 (dolastatin analogue) in patients with metastatic breast cancer

✍ Scribed by P Kerbrat; V Dieras; N Pavlidis; A Ravaud; J Wanders; P Fumoleau

Book ID
117659169
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
87 KB
Volume
39
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase II study of ionidamine in patients
Phase II study of ionidamine in patients with metastatic breast cancer
✍ H. Ian Robins; Donna S. Neuberg; Al B. Benson; Kishan J. Pandya; Douglass C. Tor πŸ“‚ Article πŸ“… 1990 πŸ› Springer US 🌐 English βš– 193 KB

The Eastern Cooperative Oncology Group conducted a phase II study of lonidamine in patients with metastatic breast cancer. The drug was given orally to a maximum daily dose of 340 mg/m 2. Forty-two patients were entered on study. One partial response was observed; there were no life-threatening toxi